117 related articles for article (PubMed ID: 11757473)
21. Evaluation of the antianginal effect of isosorbide-5-mononitrate in patients with chronic stable angina pectoris.
Yasky J; Ontanilla E; Koch JE
Cardiology; 1991; 79 Suppl 2():27-30. PubMed ID: 1760826
[TBL] [Abstract][Full Text] [Related]
22. [Stress echocardiography--a new test for evaluating the anti-ischemic effect of medication].
Leischik R; Adamczewski O; Pötter S; Erbel R; Lösse B
Z Kardiol; 1995 Aug; 84(8):621-32. PubMed ID: 7571769
[TBL] [Abstract][Full Text] [Related]
23. Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris.
Emanuelsson H; Ake H; Kristi M; Arina R
Eur J Clin Pharmacol; 1989; 36(6):561-6. PubMed ID: 2506059
[TBL] [Abstract][Full Text] [Related]
24. Double-blind randomized multicenter study on the efficacy of trapidil versus isosorbide dinitrate in stable angina pectoris.
Raubach KH; Vlahov V; Wolter K; Bussmann WD
Clin Cardiol; 1997 May; 20(5):483-8. PubMed ID: 9134282
[TBL] [Abstract][Full Text] [Related]
25. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
[TBL] [Abstract][Full Text] [Related]
26. Effects of amlodipine and isosorbide dinitrate on exercise-induced and ambulatory ischemia in patients with chronic stable angina pectoris.
Steffensen R; Melchior T; Bech J; Nissen H; Haastrup B; Grande P; Rasmussen V; Hansen JF; Skagen K; Haghfelt T
Cardiovasc Drugs Ther; 1997 Nov; 11(5):629-35. PubMed ID: 9493700
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic, anti-ischemic, and neurohumoral effects of slow-release isosorbide-5-mononitrate in patients with coronary artery disease after short- and long-term therapy.
Mitrovic V; Gessner C; Hain P; Müller KD; Schlepper M
Clin Cardiol; 1991 Mar; 14(3):209-18. PubMed ID: 1672843
[TBL] [Abstract][Full Text] [Related]
28. Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris. IMDUR Study Group.
Glasser SP
Am J Cardiol; 1997 Dec; 80(12):1546-50. PubMed ID: 9416933
[TBL] [Abstract][Full Text] [Related]
29. [Intraindividual dose-response relationship of sustained-release Elantan].
Kenedi P
Z Kardiol; 1986; 75 Suppl 3():77-9. PubMed ID: 3541420
[TBL] [Abstract][Full Text] [Related]
30. [Comparative study of retard and non-retard forms of isosorbide-5-mononitrate in coronary patients with stable angina pectoris].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Romasiuk SS; Afanas'eva IuV; Naumov VG
Klin Med (Mosk); 2000; 78(11):36-8. PubMed ID: 11232528
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of isosorbide-5-mononitrate on effort-induced electrocardiographic ischemic changes in patients with angina pectoris.
Brunner D; Meshulam N; Weisbort J
Int J Cardiol; 1987 Sep; 16(3):303-7. PubMed ID: 3654028
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of controlled-release isosorbide-5-mononitrate as adjunctive treatment to beta-blocking agents in patients with stable angina pectoris.
Svendsen JH; Aldershvile J; Abildgaard U; Amtorp O
J Cardiovasc Pharmacol; 1989 Sep; 14(3):358-63. PubMed ID: 2476613
[TBL] [Abstract][Full Text] [Related]
33. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
Thadani U; Bittar N
Am J Cardiol; 1992 Aug; 70(3):286-92. PubMed ID: 1632390
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
Parker JO; Baird MG
Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
[TBL] [Abstract][Full Text] [Related]
35. [The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort].
Metelitsa VI; Martsevich SIu; Kutishenko NP; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Slastnikova ID; Vakulovskaia MK
Ter Arkh; 1994; 66(8):22-5. PubMed ID: 7985147
[No Abstract] [Full Text] [Related]
36. Isosorbide-5-mononitrate and nifedipine can reduce ischaemic ST-segment changes during Holter monitoring in patients with spontaneous angina pectoris.
von Arnim T; Erath A; Reuschel-Janetschek E
Eur Heart J; 1988 Jan; 9 Suppl A():113-8. PubMed ID: 3409907
[TBL] [Abstract][Full Text] [Related]
37. [A new anti-ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate].
Lai C; Onnis E; Solinas R; Orani E; Lai G; Cadeddu M; Cherchi A
Cardiologia; 1991 Sep; 36(9):703-11. PubMed ID: 1839369
[TBL] [Abstract][Full Text] [Related]
38. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
Gunasekara NS; Noble S
Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
[TBL] [Abstract][Full Text] [Related]
39. [Effects of slow-release isosorbide-5-mononitrate on ergometric parameters and cardiac output in stable effort angina pectoris: a double-blind randomized placebo study].
Romeo F; Barillà F; Pelliccia F; Ferraironi A; Ciolli A; Pannarale G; Vicchio D; Valente A
Cardiologia; 1989 Jul; 34(7):643-50. PubMed ID: 2676173
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]